ASBP · Aspire Biopharma Holdings, Inc.
$8.87
-0.38 (-4.11%)
At close · Sep 4
View the 10-Q filed Aug 13, 2026
Customer concentration
— top customer 15% of revenue
One customer — 15% of revenue (the six months ended June 30, 2026)
“One customer accounted for approximately 15% of the Company’s total revenues during the six months ended June 30, 2026.”
Market Cap
$12.62M
Shares
1.40M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Coverage backlog: 62 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.